Infection around joint replacements in patients who have a renal or liver transplantation.

The results of thirty-five joint (hip or knee) replacements in nineteen patients who had an organ transplantation were retrospectively reviewed. The patients received a standard immunosuppressive induction regimen at the time of the transplantation and were maintained on a combination of prednisone, azathioprine, and cyclosporine A. All patients received antibiotics perioperatively, but antibiotic-impregnated bone cement was not used for any procedure. Six joint replacements, in three patients who were an average of 48.2 years old at the time of the arthroplasty, were performed before a renal transplantation. Twenty-four joint replacements, in fourteen patients who were an average of 40.9 years old at the time of the arthroplasty, were performed after an organ transplantation. Two patients, who were an average of 53.8 years old at the time of the arthroplasty, each had a joint replacement both before and after a liver transplantation (a total of five joint replacements). The average duration of follow-up from the first joint replacement was 8.8 years (range, one to twenty-three years). The Harris hip score or The Hospital for Special Surgery knee score was determined at the time of the latest follow-up examination. An infection developed around the implant in five patients who had had the joint replacement after a transplantation. The average interval from implantation of the prosthesis until detection of the infection was 3.4 years (range, one to six years). One patient who had a liver transplant was infected with Pseudomonas aeruginosa and another one was infected with Escherichia coli. One patient who had a renal transplant was infected with Staphylococcus epidermidis; one, with Enterococcus; and one, with Serratia marcescens. We found that patients who had a joint replacement after an organ transplantation had a very high risk of devastating infection. The rate of such infection was 19 per cent (five of twenty-seven joint replacements in sixteen patients).

An ultrasound method to evaluate polyethylene component wear in total knee replacement arthroplasty.

Evaluation of a painful total knee replacement has been limited to physical examination, aspiration, plain radiographs, and radionuclide studies. Visualization of the polyethylene tibial-bearing component without surgery has not been possible. Polyethylene wear is a well-recognized cause of total knee replacement failure. We have developed an ultrasound method to evaluate polyethylene insert shape and thickness with the ability to clearly demonstrate structural loss of plastic. Before clinical trials, a total knee replacement was cemented into a fresh cadaver knee. Ultrasound imaging of the polyethylene insert was performed in the longitudinal plane using a 10 MHz linear transducer. A characteristic bone/metal/polyethylene interface enabled recognition of the insert material from which its dimension was estimated. The entire perimeter of the liner, the metal tray, and the bone-metal interface was visualized. Five consecutive measurements at each location were performed on each of the 8-, 10-, and 12-mm polyethylene liners with the ultrasonographer blind to the insert thickness. Once removed, measurements were made directly on the liners adjacent to the marked points with an electronic caliper. Coefficient of variation (r2) ranged from 1.6% to 8.3% for the ultrasound measurements, and 0.26% to 1.5% for the caliper measurements. A plot of ultrasound versus caliper measurements allowed calculation of a linear equation, with r2 = 0.98, demonstrating high correlation between the two measurements. Our ultrasound measurements are accurate to 0.5 mm with a 95% confidence interval. Ultrasound is an accurate way to measure the dimensions of the polyethylene liner in total knee replacement arthroplasty. Early experiences with ultrasound evaluation prior to revision have been very encouraging for the evaluation of polyethylene wear, defects, and of prosthetic loosening.

Autogenous bone banking in a contralateral total hip arthroplasty. A case report.

The operative technique of autogenous bone banking of a femoral head from a symptomatic degenerative hip undergoing a primary total hip arthroplasty into an osseous deficiency of an asymptomatic, contralateral, loose acetabular component is described. The rationale for bone banking an autogenous femoral head versus the use of an allograft or iliac crest autograft at a later date is discussed.

Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty.

Duplex ultrasonography of the lower extremity was used for routine non-invasive screening for asymptomatic proximal and distal deep venous thrombosis, for monitoring of potential propagation of deep venous thrombosis from distal to proximal, and for confirmation of the resolution of proximal deep venous thrombosis after treatment. In the first part of the study, to substantiate the accuracy of duplex ultrasonography, 130 lower limbs (seventy-nine patients) were studied with that modality as well as with venography after a total hip or total knee arthroplasty. Compared with venography, duplex ultrasonography demonstrated 100 per cent sensitivity, specificity, and accuracy for the detection of proximal deep venous thrombosis and 88 per cent sensitivity, 98 per cent specificity, and 98 per cent accuracy for the detection of distal deep venous thrombosis. In the second part of the study, 100 patients who had had a total knee arthroplasty and had been managed with pneumatic stockings and aspirin for prophylaxis against deep venous thrombosis had screening of both lower extremities with duplex ultrasonography on the fourth postoperative day. Duplex ultrasonography demonstrated proximal deep venous thrombosis in seven patients and distal deep venous thrombosis in twenty-two patients; all twenty-nine patients were asymptomatic. The patients who had distal deep venous thrombosis had surveillance with serial duplex ultrasonography on the seventh and fourteenth postoperative days; five of these patients were found to have had propagation of the thrombosis to the proximal deep veins.(ABSTRACT TRUNCATED AT 250 WORDS)

The clinical course of distal deep venous thrombosis after total hip and total knee arthroplasty, as determined with duplex ultrasonography.

Duplex ultrasonography was used to screen 273 consecutive patients, on the fourth day after a total hip or total knee arthroplasty, for the presence of a distal deep venous thrombosis. Patients who had a history of thromboembolic disease or who had an active neoplasm were excluded from the study. Of the 273 patients, twenty-four (9 per cent) were found to have a proximal deep venous thrombosis (a thrombosis involving the femoral or popliteal veins) and forty-one (15 per cent), a distal deep venous thrombosis (a thrombosis involving the veins of the calf). All of the thromboses were asymptomatic. The forty-one patients in whom a distal deep venous thrombosis had been detected with duplex screening subsequently had serial duplex examinations, on the seventh and fourteenth postoperative days. If a proximal deep venous thrombosis was detected, anticoagulation was begun immediately. If no proximal thrombosis was observed, the distal thrombosis was considered stable, the serial duplex examinations were terminated, and clinical observation was continued. Of the forty-one patients who had serial examinations, seven (17 per cent) had a proximal deep venous thrombosis in the ipsilateral limb by the fourteenth postoperative day; all seven were asymptomatic, and all were managed with anticoagulation. Thirty-four patients (83 per cent) were determined to have a stable distal deep venous thrombosis on the fourteenth postoperative day, and no additional duplex examinations were performed. Thirty-three (97 per cent) of these thirty-four patients remained asymptomatic for deep venous thrombosis thereafter; the remaining patient (3 per cent) had a proximal deep venous thrombosis in the ipsilateral limb eleven months postoperatively.(ABSTRACT TRUNCATED AT 250 WORDS)

Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis. A survey of 110 total hip arthroplasties.

The use of duplex ultrasonography for routine noninvasive screening, monitoring, and management of deep venous thrombosis after total hip arthroplasty was evaluated. The reliability of duplex ultrasonography for detection of deep vein thrombosis was confirmed in an initial cohort of 51 total hip arthroplasty patients (102 lower extremities), demonstrating 91% sensitivity, 98% specificity, and 97% accuracy when compared with venography. A second cohort of 110 total hip arthroplasty patients using pneumatic compression stockings and aspirin as deep vein thrombosis prophylaxis underwent screening duplex ultrasonography of both lower extremities on postoperative Day 4. Duplex ultrasonography screening showed 10 (9.1%) patients with proximal deep vein thrombosis and 10 (9.1%) with distal deep vein thrombosis, all of whom were asymptomatic. The 10 patients with proximal deep vein thrombosis on duplex ultrasonography were prescribed therapeutic anticoagulation. Duplex ultrasonography subsequently confirmed resolution of proximal deep vein thrombosis in these patients before discontinuation of anticoagulation; none developed symptomatic pulmonary embolism through 12-month clinical followup. The 10 patients with distal deep vein thrombosis diagnosed by duplex ultrasonography were not treated with anticoagulation, but were monitored by serial duplex ultrasonography through postoperative Day 14 for propagation of distal to proximal deep vein thrombosis; none manifested symptomatic deep vein thrombosis or pulmonary embolism through 12-month clinical followup. The 90 patients with negative duplex ultrasonography results were followed clinically; 3 developed late symptomatic proximal deep vein thrombosis (1 of these later manifested pulmonary embolism). Therefore, duplex ultrasonography was used after total hip arthroplasty for the following: (1) to screen routinely in the hospital for asymptomatic proximal and distal deep vein thrombosis; (2) to monitor for potential propagation of distal to proximal deep vein thrombosis; (3) to minimize exposure to therapeutic anticoagulation by confirming the absence of proximal deep vein thrombosis in 97 of 110 patients; and (4) to demonstrate the effectiveness of mechanical and systemic deep vein thrombosis management by confirming the absence or resolution of deep vein thrombosis in all 110 patients.